A study on the inhibition of adenosine deaminase

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 23, Issue 2, 2008, Pages 182-189

  Alunni, Sergio ^a   Orrù, Mara ^a   Ottavi, Laura ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Adenosine deaminase; Inhibition; Kinetics; Mechanism

Indexed keywords

2 AMINOPURINE; 4 AMINOPYRIDINE; 4 AMINOPYRIMIDINE; 4 HYDROXYPYRIDINE; ADENINE; ADENOSINE DEAMINASE; ENZYME INHIBITOR; INOSINE; PHENYLHYDRAZINE; PURINE; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; CHEMICAL INTERACTION; CHEMICAL STRUCTURE; COMPETITIVE INHIBITION; CONTROLLED STUDY; COW; ENZYME CHEMISTRY; ENZYME INHIBITION; ENZYME STRUCTURE; ENZYME SUBSTRATE; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; SPLEEN;

ADENOSINE DEAMINASE; ANIMALS; CATTLE; ENZYME INHIBITORS; MOLECULAR STRUCTURE; SPLEEN; STRUCTURE-ACTIVITY RELATIONSHIP;

BOVINAE;

EID: 40949109275     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.1080/14756360701475233     Document Type: Article

References (47)

1. Cristalli, G., Costanzi, S., Lambertucci, C., Lupidi, G., Vittori, S., Volpini, R. and Campioni, E. (2001) Adenosine deaminase: Functional implications and different classes inhibitors. Med Res Rew, 21, pp. 105-128.
2. Lupidi, G., Marmocchi, F., Falasca, M., Venardi, G., Cristalli, G., Grifantini, M., Withehead, E. and Riva, F. (1992) Adenosine deaminase from Saccharomyces cerevisiae: Kinetics and interaction with transition and ground state inhibitors. Biochim Biophys Acta, 1122, pp. 311-316.
3. Aikawa, T., Umemori-Aikawa, Y. and Fisher, JR (1977) Purification and properties of the adenosine deaminase from the midgut gland of a marine bivalved mollusc. Atrina spp Comp Biochem Physiol, 58, pp. 357-364.
4. Ma, PF and Fisher, JR (1968) Two different hepatic adenosine deaminase in the chicken. Biochim Biophys Acta, 159, pp. 153-159.
5. Brady, TG and O'Donovan, CI (1965) Tissue distribution of adenosine deaminase in six mammal species. Comp Biochem Physiol, 14, pp. 101-119.
6. Lupidi, G., Marmocchi, F., Falasca, M., Venardi, G., Cristalli, G. and Riva, F. (1992) Adenosine deaminase from bovine brain: Purification and partial characterization. Biochem Int, 26, pp. 1053-1063.
7. Argwal, RP, Sagar, SM and Parks Jr, RE (1975) Adenosine deaminase from human erythrocytes: Purification and effects of adenosine analogs. Biochem Pharmacol, 24, pp. 693-701.
8. Daddona, PE and Kelly, WN (1980) Analysis of normal and mutants forms of human adenosine deaminase. J Biol Chem, 252, pp. 110-115.
9. Daddona, PE (1981) Human adenosine deaminase: Properties and turnover in cultured T and B lymphoblast. J Biol Chem, 256, pp. 12496-12501.
10. Kelly, MA, Vestling, MM, Murphy, CM, Hua, S., Sumpter, T. and Fenselau, C. (1996) Primary structure of bovine adenosine deaminase. J Pharm Biomed Anal, 14, pp. 1513-1519.
11. Kinoshita, T., Nishio, N., Sato, A. and Murata, M. (1999) Crystallization and preliminary analysis of bovine adenosine deaminase. Acta Crystallogr, pp. 2031-2032.
12. Gleeson, MP, Burton, NA and Hillier, IH (2003) The mechanism of adenosine deaminase catalysis studied by QM/MM calculations: The role of histidine 238 and the activity of the alanine 238. Phys Chem Chem Phys, 5, pp. 4272-4278.
13. Cass, CE and Au-Yeung, TH (1976) Enhancement of 9-beta-d-arabinofuranosyladenine cytotoxicity to mouse leukemia L1210 in vitro by 2′-deoxycoformycin. Cancer Res, 36, pp. 1486-1491.
14. Johns, DG and Adamson, RH (1976) Enhancement of the biological activity of cordycepin(3′-deoxyadenosine) by the adenosine inhibitor 2′-deoxycoformycin. Biochem Pharmacol, 25, pp. 1441-1444.
15. LePage, GA, Worth, IS and Kimball, AP (1976) Enhancement of the antitumor activity of arabinofuranosyladenine by 2′-deoxycoformicin. Cancer Res, 36, pp. 1481-1485.
16. Adamson, RH, Zaharevitz, DW and Johns, DG (1977) Enhancement of the biological activity of adenosine analogs by the adenosine deaminase inhibitor 2′-deoxycoformycin. Pharmacology, 15, pp. 84-89.
17. Glazer, RI, Lott, TJ and Peale, AL (1978) Potentiation by 2′-deoxycoformycin of the inhibitory effect by 3′-deoxyadenosine(cordycepin) on nuclear RNA synthesis in L210 cells in vitro. Cancer Res, 38, pp. 2233-2238.
18. Iliakis, G. and Ngo, FQH (1985) Effects of adenosine deaminase inhibitor 2′-deoxycoformycin on the repair and expression of potentially lethal damage sensitive to β-araA. Radiat Environ Biophys, 24, pp. 81-88.
19. Sciotti, VM and Van Wylen, DGL (1993) Increases in interstitial adenosine and cerebral blood flow with inhibition of adenosine kinase and adenosine deaminase. J Cerebral Blood Flow Metab, 13, pp. 201-207.
20. Llyod, HGE and Fredholm, BB (1995) Involvement of adenosine deaminase and adenosine kinase in regulating extracellular adenosine concentration in rat hippocampal slices. Neurochem Int, 26, pp. 387-395.
21. Golembiowska, K., White, TD and Sawynok, J. (1995) Modulation of adenosine release from rat spinal cord by adenosine deaminase and adenosine kinase inhibitors. Brain Res, 699, pp. 315-320.
22. White, TD (1994) Pharmacological augmentation of excitatory amino acid-evoked adenosine release from rat cortical slices. Drug Dev Res, 31, p. 333.
23. White, TD (1996) Potentation of excitatory amino acid-evoked adenosine release from rat cortex by inhibitors of adenosine kinase and adenosine deaminase and by acadesine. Eur J Pharmacol, 303, pp. 27-38.
24. Hebb, MO and White, TD (1998) Co-administration of adenosine kinase and deaminase inhibitors produces supra-additive potentiation of N-methyl-D-aspartate-evoked adenosine formation in cortex. Eur J Pharmacol, 344, pp. 121-125.
25. Poon, A. and Saynok, J. (1999) Antinociceptive and anti-inflammatory properties of an adenosine kinase inhibitor and an adenosine deaminase inhibitor. Eur J Pharmacol, 384, pp. 123-138.
26. Tofovic, SP, Kusaka, H., Li, P. and Jackson, EK (1998) Effects of adenosine deaminase inhibition on blood pressure in old spontaneously hypertensive rats. Clin Exp Hyperten, 20, pp. 329-344.
27. Langer, M., Pauling, A. and Rétey, J. (1995) The role of dehydroalanine in catalysis by histidine ammonia lyase. Angew Chem Int Ed Engl, 34, pp. 1464-1465.
28. Abeles, RH, Frey, PA and Jencks, WP (1992) Biochemistry, Jones and Bartlett Publisher
29. Voet, D. and Voet, JG (1990) Biochemistry, John Wiley and sons
30. Alunni, S., Conti, A. and Palmizio, ER (2000) Mechanism and proton activating factors in base-induced β-elimination reactions of N-[2-(4-pyridyl)ethyl]quinuclidinium and N-[2-(2-pyridyl)ethyl]quinuclidinium salts. J Chem Soc Perkin Trans, 2, pp. 453-457.
31. Alunni, S., Conti, A. and Palmizio, ER (2001) Use of solvent isotope effect to identify an intermediate carbanion in the β-elimination reactions from N-[2-(4-pyridyl)ethyl]quinuclidinium and N-[2-(2-pyridyl)ethyl]quinuclidinium induced by acetohydroxamate/ acetohydroxamic acid buffers. Res Chem Intermed, 27, pp. 635-641.
32. Alunni, S. and Busti, A. (2001) Mechanism and proton activating factors in base-induced β-elimination reactions of 2-(2-chloroethyl)pyridine. J Chem Soc Perkin Trans, 2, pp. 778-781.
33. Alunni, S., Laureti, V., Ottavi, L. and Ruzziconi, R. (2003) Catalysis of the β-elimination of HF from isomeric 2-fluoroethylpyridines and 1-methyl-2- fluoroethylpyridinium salts. Proton-activating factors and methyl-activating factors as a mechanism test to distinguish between concerted E2 and E1cb irreversible mechanisms. J Org Chem, 68, pp. 718-725.
34. Alunni, S. and Ottavi, L. (2004) Mechanism of acid-base catalysis of β-elimination reactions in systems activated by a pyridine ring. AJ Org Chem, 69, pp. 2272-2283.
35. Alunni, S., De Angelis, F., Ottavi, L., Papavasileiou, M. and Tarantelli, F. (2005) Evidence of a borderline region between E1cb and E2 elimination reaction mechanisms: A combined experimental and theorical study of systems activated by the pyridine ring. J Am Chem, 127, pp. 15151-15160.
36. Frieden, C., Kurz, LC and Gilbert, HR (1980) Adenosine deaminase and adenylate deaminase: Comparative kinect studies with transition state and ground state analog inhibitors. Biochemistry, 19, pp. 5303-5309.
37. Lerner, LM and Rossi, RR (1972) Inhibition of adenosine deaminase by alcohols derived from adenine nucleosides. Biochemistry, 11, pp. 2772-2777.
38. Schaeffer, HJ, Johnson, RN, Odin, E. and Hansch, C. (1970) Structure-activity relationships in adenosine deaminase inhibitors. J Med Chem, 13, pp. 452-455.
39. Saboury, AA, Divsalar, A., Jafari, GA, Mossavi-Movahedi, AA, Housaindokht, MR and Hakimelahi, GH (2002) A product inhibition study on adenosine deaminase by spectroscopy and calorimetry. J Biochem Mol Biol, 35, pp. 302-305.
40. Ogawa, T., Aikawa, Y. and Aikawa, T. (1987) Kinetic characteristics and binding process of substrate analogs to the adenosine deaminase in the marine mussel, mytilus edulis. Comp Biochem Physiol, 88:1, pp. 91-100.
41. Wolfenden, R. (1969) On the rate-determining step in the action of adenosine deaminase. Biochemistry, 8:6, pp. 2409-2412.
42. Saboury, AA, Divsalar, A., Ataie, G., Amanlou, M., Moosavi-Movahedi, AA and Hakimelahi, GH (2003) Inhibition study of adenosine deaminase by caffeine using spectroscopy and isothermal titration calorimetry. Acta Biochem Pol, 50, pp. 849-855.
43. Aikawa, T., Aikawa, Y. and Brady, TG (1980) The pH-dependence of the inhibitory effects of several divalent cations on the bovine intestine adenosine deaminase activity. Int J Biochem, 12, pp. 493-495.
44. Copeland, A. (1996) Enzymes, VCH Publisher, Inc.
45. Dixon, M. (1953) The effect of pH on the affinities of enzymes for substrates and inhibitors. Biochem J, 55, pp. 161-170.
46. Isaac, NS (1987) Physical organic chemistry, Langman Scientific and Technical, Harlow, Essex, England
47. Bruice, TC and Dixon, JE (1971) α-effects IV. Additional observation on the α;-effect employing malachite green as substrate. J Am Chem Soc, 93, pp. 6592-6597.